Advanced Biomed Inc
Cash Flow Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-488.9K | $6.9M | $-386.9K | $-1.4M | $-907.9K | $-265.6K | $-1.1M | $-145.3K |
| Depreciation & Amortization | — | — | $48.0K | — | — | $102.2K | — | — |
| Depreciation | $9.3K | $14.5K | $48.0K | $22.5K | $22.0K | $67.3K | $51.1K | $57.9K |
| Amortization | — | — | — | $30.2K | $33.6K | — | $31.9K | $31.7K |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-239.8K | $-513.6K | $-610.3K | $-3.4M | $-841.8K | $-29.7K | — | — |
| Investing Activities | ||||||||
| Capital Expenditures | $1.3K | $12.9K | $1.8K | $2.2K | $-10.7K | $20.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-1.8K | — | — | $-20.0K | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $447.5K | — | — | $392.5K | — | — |
| Net Change in Cash | — | — | $-247.4K | — | — | $39.0K | — | — |
| Free Cash Flow | $-241.0K | $-526.5K | $-612.1K | $-3.4M | $-831.1K | $-49.7K | — | — |